Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Apr
01
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Mar
27
Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated diseases and HCPs
Mar
16
3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time
Mar
10
Innovation Equals Access: How UCB Delivered for Patients in 2025
Feb
04
More than Medicine: UCB's Holistic Approach to Supporting MG Patients
Dec
03
Bridging Strategy and Innovation: Leadership in Action through the AES BRIDGE Program
Nov
14
When Every Second Matters
Nov
04
Elevating the lives of people impacted by thymidine kinase 2 deficiency (TK2d)
Oct
31
Redefining Hidradenitis Suppurativa (HS) Care Through Community and Collaboration
